Position in PFE
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$649,702
+$44,438 QoQ
Shares Held
26,981
+25.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,581
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Soltis Investment Advisors LLC holds $50,374,735 across 12 Drug Manufacturers - General names. PFE ranks #7 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
49,990 | $12,695,960 | |
| 2 | AMGN |
Amgen Inc
|
29,172 | $10,563,764 | |
| 3 | ABBV |
AbbVie Inc.
|
35,875 | $9,027,585 | |
| 4 | LLY |
ELI LILLY & Co
|
5,809 | $6,967,489 | |
| 5 | MRK |
Merck & Co., Inc.
|
48,517 | $6,234,434 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
42,594 | $2,454,266 | |
| 7 | PFE |
Pfizer Inc
This page
|
26,981 | $649,702 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,981 | $629,299 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $649,702 | 26,981 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $605,264 | 21,555 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $435,301 | 17,482 | Shares | Sole | 2026-04-02 | |
| 2025-09-30 | $520,785 | 20,439 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $359,115 | 14,815 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $2,765,202 | 109,124 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $439,655 | 16,572 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $737,072 | 25,469 | Shares | Sole | 2025-01-03 | |
| 2024-06-30 | $5,170,536 | 184,794 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $5,127,145 | 184,762 | Shares | Sole | 2024-05-29 | |
| 2023-12-31 | $4,796,270 | 166,595 | Shares | Sole | 2024-01-26 | |
| 2023-09-30 | $5,874,572 | 177,105 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $5,961,490 | 162,527 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $5,662,999 | 138,799 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $6,205,830 | 121,113 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $4,734,438 | 108,191 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,684,825 | 127,500 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $4,198,339 | 81,096 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $4,088,031 | 69,230 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $2,918,873 | 67,865 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $2,593,292 | 66,223 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $2,088,695 | 57,651 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $1,736,290 | 47,169 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,388,066 | 37,822 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $1,076,288 | 32,914 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $859,997 | 26,348 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||